Le Min is an Endocrinology/Metabolic physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 62 publications with 3,767 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
63.5%RANK Ligand Inhibitor63.5%Denosumab100%Part B, office-administered≥18 patientsHormonal (systemic)
19.1%l-Thyroxine15.3%Levothyroxine Sodium74%Synthroid23%Levoxyl3%Part D<11 patientsl-Triiodothyronine1.4%Liothyronine Sodium100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
8.2%Biguanide (metformin)2.4%Metformin Hcl54%Metformin Hcl Er47%Part D<11 patientsSGLT2 inhibitor2.2%Jardiance72%Farxiga28%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2012–2016 per NIH RePORTER. The latest:
- Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
Brigham and Women'S Hospital
FY2016$137,970K08HD070957 - Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
Brigham and Women'S Hospital
FY2015$137,970K08HD070957 - Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
Brigham and Women'S Hospital
FY2014$137,970K08HD070957
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”